Please consider making a tax-deductible donation to the Australian Rheumatology Association. Your support helps fund vital research, education, and advocacy for Australians living with arthritis and musculoskeletal conditions.
Updated June 2026
Ixekizumab (brand name: Taltz®) is a medicine for adults with psoriatic arthritis, a type of joint inflammation ofen seen with psoriasis (a skin condition). It is also used for adults with moderate to severe chronic (long lasting) plaque psoriasis.
Ixekizumab is also used to treat adults with axial spondyloarthritis, including ankylosing spondylitis, which causes pain and stiffness in the spine because of inflammation in the spinal joints.
Ixekizumab works by blocking a protein called IL-17A that drives inflammation and results in stiff and painful joints in people with psoriatic arthritis and axial spondyloarthritis. As a result, ixekizumab can reduce inflammation and the pain and stiffness caused by too much IL-17A.
You may notice joint swelling, pain and stiffness gets better within the first 8 weeks of starting ixekizumab.
If you stop or delay your ixekizumab treatment, your condition might get worse. You should stay on the treatment unless your rheumatologist tells you to stop or if you get side effects (see Side effects). If you stop ixekizumab for any reason, you must contact your rheumatologist. If you don’t, your treatment may stop being subsidised by Medicare.
Medicines like ixekizumab are very expensive but Medicare usually helps cover the cost if you meet certain conditions.
Ixekizumab is injected just under the skin of the thigh or belly. It is best to avoid (if possible) any areas of skin affected by psoriasis. The prefilled autoinjector or syringe should be taken out of fridge 30 minutes before injecting so it can reach room temperature. Do not shake or freeze it. It can be injected by your doctor, nurse, carer, or by you. If injecting yourself, be sure to follow the detailed instructions carefully to ensure the best response. It is important to change the injection site each time.
Give the next injection as soon as you remember and continue to use it as you normally would. Do not inject a double dose to make up for a missed dose. If you have missed more than one dose or are not sure what to do, check with your doctor or pharmacist.
Ixekizumabcomes in a prefilled syringe or pen which has 80 mg of medicine. The usual starting dose is:
This medicine may be used alone or with other arthritis medicines including:
You might experience side effects with your treatment. Tell your doctor if you notice side effects that you think are caused by this medicine. Many side effects disappear when ixekizumab treatment is stopped.
You may have more mild upper respiratory tract infections (common cold, sinus infections), nausea, diarrhoea, cough, and fever. Infections may need treatment and ixekizumab may need to be stopped for a while during an infection, so it is important to contact your doctor for advice.
There are some rare but sometimes serious side effects with ixekizumab, including:
If you have an active infection, treatment with ixekizumab will not be started until the infection is treated.
Before starting ixekizumab, your rheumatologist may screen you for some infections, including hepatitis B and C, HIV and tuberculosis. In most people this is done by asking you about possible past exposure to these infections and with a blood test, but some rheumatologists may choose to do a chest X-ray as well.
Ixekizumab can affect and be affected by other medicines. You should tell all your doctors about all medicines you are taking or plan to take. This includes over the counter or herbal/natural medicines.
Ixekizumab should not be used while having light therapy (PUVA) for psoriasis.
If you need surgery for any reason, you should discuss this with your rheumatologist as some people might need to stop taking ixekizumab before surgery
You may drink alcohol while taking ixekizumab. However, if you are also taking methotrexate, you should be cautious about how much alcohol you drink.